Stocks · Health care · Pharmaceutical Preparations

Nuvation Bio Inc.

NUVB Clue Score46
United States Fiscal year ends December CIK 0001811063 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Junyuan Jerry Wang
11 Nov 2024
CEO, Anheart Therapeutics Ltd.
Sell
56,361
$2.89
$162.88K
Omega Fund V, L.P.
5 Apr 2022
10% owner
Sell
2,500,000
$5.60
$14.00M
Omega Fund V, L.P.
15 Dec 2021
10% owner
Sell
500,000
$10.07
$5.04M
Omega Fund V, L.P.
7 Dec 2021
10% owner
Sell
1,400,000
$9.80
$13.72M
Omega Fund V, L.P.
23 Nov 2021
10% owner
Sell
36
$9.75
$351.00
Omega Fund V, L.P.
22 Nov 2021
10% owner
Sell
295,000
$9.76
$2.88M
Omega Fund V, L.P.
3 Nov 2021
10% owner
Sell
2,000,000
$9.25
$18.50M
Omega Fund V, L.P.
29 Oct 2021
10% owner
Sell
45,000
$9.27
$417.15K
Omega Fund V, L.P.
28 Oct 2021
10% owner
Sell
1,015,000
$9.60
$9.74M
Oleg Nodelman
31 Jul 2021
Director
Sell indirect
56,598
$8.64
$489.01K
Oleg Nodelman
31 Mar 2021
Director
Sell indirect
151,544
$10.45
$1.58M

What was left out

Form 4 filings counted 146
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 18
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 114,572,402
Sales filed before the plan box existed 10
History held since 6 Jul 2020